Dermira, Inc. (DERM) [Rocket]

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenue:
Total revenue	42.3	4.5	22.6	7.3	7.3	22.6
Total revenue growth	832.4%	-79.9%	209.4%	0.0%	-67.7%
Costs and operating expenses:
Cost of sales	1.2
Research and development	80.5	104.4	83.2	66.8	30.7	17.9	17.1
Selling, general and administrative	172.6	71.9	30.0
Impairment of intangible assets	1.1			2.4
Total costs and operating expenses	257.5	304.9	113.2
Loss from operations	-214.0	-300.3	-90.6	-79.6	-31.7	-22.3	-20.2
Operating margin	-505.4%	-6613.7%	-401.3%	-1091.0%	-434.2%	-98.7%
Interest and other income, net	7.9	5.2	1.5	0.9
Interest expense	-15.6	-8.1		-0.1	-0.2	0.0	-0.1
Loss before taxes	-221.7	-303.3	-89.1	-79.0	-31.8	-22.4	-20.3
Benefit for income taxes	0.2			0.6	0.0
Net loss	-221.5	-303.3	-89.1	-78.4	-31.9	-22.4	-20.3

Net loss per share, basic and diluted	($5.27)	($7.48)	($2.70)	($2.93)	($4.96)	($27.03)	($27.99)

Weighted-average common shares used to compute net loss per share, basic and diluted	42.0	40.6	33.0	26.7	6.4	0.8	0.7